<DOC>
	<DOCNO>NCT02163629</DOCNO>
	<brief_summary>In spite major medical advance heart transplant patient , psychiatric comorbidity remain high pre-and post-transplant phase . Anxiety depression especially frequent . They impact significantly morbidity mortality . Especially associated poor therapeutic adherence risk infection rejection . The inability make beneficial therapeutic choice explain negative perception event , associate anxio-depressive disorder . This result important deterioration quality life patient . The investigator assume good management emotion might reduce stress wait situation psychopathological somatic consequence pre-and post-transplant .</brief_summary>
	<brief_title>Impact Stress Management Training After Cardiac Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Psychotropic Drugs</mesh_term>
	<criteria>Men woman cardiac transplantation wait list Patients age 18 year old Signed write informed consent Patients social security Patients somatic condition allow travel Patients master French language Class II III NYHA patient Patients minor protection measure Patient sign write informed consent Patients master French language Patients psychiatric illness characterize axis 1 DSM IV R Patients receive psychotherapy psychiatric care class IV NYHA patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Psychotherapeutic intervention</keyword>
	<keyword>stress management</keyword>
	<keyword>cardiac transplantation</keyword>
	<keyword>quality life</keyword>
</DOC>